サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605765

持続皮下インスリン注入市場：製品タイプ別、患者タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Continuous Subcutaneous Insulin Infusion Market, By Product Type, By Patient Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 388 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
持続皮下インスリン注入市場：製品タイプ別、患者タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月28日
発行: AnalystView Market Insights
ページ情報: 英文 388 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートのハイライト

持続皮下インスリン注入市場規模は2023年に42億4,500万米ドルとなり、2024年から2032年にかけてCAGR 9.89%で拡大

持続皮下インスリン注入市場-市場力学

高度なインスリン送達デバイスに対する意識の高まりが市場需要を促進

持続皮下インスリン注入（CSII）市場は、糖尿病罹患率の上昇と高度なインスリン送達に対する意識の高まりによって牽引されており、現在1型糖尿病患者の40%がインスリンポンプを使用しています。しかし、高いヘルスケアコストと限られたアクセシビリティが業界の成長を妨げる可能性があります。逆に、ポンプの機能性と患者体験を向上させるAIとIoTの革新にチャンスがあり、データ統合の拡大とグルコースコントロールの改善を約束する人工膵臓システムの進歩もあります。

持続皮下インスリン注入市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約9.89％のCAGRで毎年成長すると推定されます。

製品タイプ別では、テザーポンプが2023年に最大市場シェアを示すと予測されました。

患者タイプ別では、タイプ1が2023年に主要タイプに

地域別では、2023年に北米が主要な収益源となった。

持続皮下インスリン注入市場-セグメンテーション分析：

世界の持続皮下インスリン注入市場は、製品タイプ、患者タイプ、最終用途、地域に基づいてセグメント化されます。

市場は製品タイプにより、パッチポンプとテザーポンプの3つに分類されます。テザーポンプの分野が市場を独占しています。空気対空気ヒートポンプはメンテナンスがほとんど必要なく、設置も簡単です。地盤工事が不要で費用対効果が高いため、地中熱ヒートポンプシステムよりも選ばれています。

市場は、患者のタイプによってタイプ1とタイプ2に分けられます。タイプ1が市場を独占しており、予測期間中もその優位性は維持されると思われます。その主な理由は、アクセスのしやすさと携帯性にあり、大きな市場シェアを獲得しています。これらのデバイスは、衣服の下または外側に簡単に装着でき、インスリン管理の利便性を提供します。

持続皮下インスリン注入市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

持続皮下インスリン注入市場-競合情勢：

世界市場は、ユーザーフレンドリーな技術と血糖コントロールの改善を重視した、先進的なインスリン管理ソリューションの採用拡大が牽引しています。市場戦略には、グルコースモニタリングシステムとの機器統合を強化するための提携が含まれ、プロアクティブな糖尿病管理のためのリアルタイムデータと予測分析が可能になります。さらに各社は、特に多様な層にわたる1型糖尿病の管理において、特定の患者のニーズに応えるため、コンパクトで目立たないインスリンポンプやカスタマイズ可能な投与オプションの開発に注力しています。

目次

第1章 持続皮下インスリン注入市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 持続皮下インスリン注入の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 持続皮下インスリン注入産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 持続皮下インスリン注入市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 持続皮下インスリン注入市場情勢

  • 持続皮下インスリン注入市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 持続皮下インスリン注入市場-製品タイプ別

  • 概要
    • セグメントシェア分析
    • パッチポンプ
      • Basal & Bolusインスリン療法
      • Basalインスリン療法
      • Bolusインスリン療法
    • テザーポンプ
      • バッテリー
      • インスリンセット挿入器具
      • インスリンリザーバーとカートリッジ

第8章 持続皮下インスリン注入市場- 患者タイプ別

  • 概要
    • セグメントシェア分析
    • タイプ1
    • タイプ2

第9章 持続皮下インスリン注入市場- 最終用途別

  • 概要
    • セグメントシェア分析
    • 研究所
    • ホームケア
    • 病院

第10章 持続皮下インスリン注入市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 持続皮下インスリン注入業界

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • Medtronic Inc.
    • CeQur
    • Tandem Diabetes Care
    • F Hoffmann-La Roche
    • Ypsomed
    • Insulet Corporation
    • Sooil Development
    • Valeritas Inc.
    • Cellenovo
    • B. Braun Melsungen AG
    • Bigfoot Biomedical, Inc.
    • Becton, Dickinson and Company
    • Fresenius SE &Co. KGaA
    • MicroPort Scientific Corporation
    • MannKind Corporation
    • Nipro Corporation
    • Shinmyung Mediyes CO., LTD.
    • Sanofi SA
    • Smiths Group PLC
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4325

REPORT HIGHLIGHT

Continuous subcutaneous insulin infusion market size was valued at USD 4,245 Million in 2023, expanding at a CAGR of 9.89% from 2024 to 2032.

Continuous subcutaneous insulin infusion (CSII) is a diabetes management method that uses an insulin pump to deliver small, continuous doses of rapid-acting insulin under the skin. This method mimics the body's natural insulin release, which helps in maintaining stable blood glucose levels. Patients can adjust doses for meals or exercise, offering flexibility and better glycemic control. CSII is especially beneficial for individuals with type 1 diabetes who require precise insulin regulation throughout the day and night.

Continuous Subcutaneous Insulin Infusion Market- Market Dynamics

Growing awareness about advanced insulin delivery devices to propel market demand

The continuous subcutaneous insulin infusion (CSII) market is driven by rising diabetes rates and increased awareness of advanced insulin delivery, with 40% of type 1 diabetes patients currently using insulin pumps. However, high healthcare costs and limited accessibility may hamper the industry's growth. On the contrary, Opportunities lie in AI and IoT innovations that enhance pump functionality and patient experience, alongside the advancement of artificial pancreas systems which promise expanded data integration and improved glucose control.

Continuous Subcutaneous Insulin Infusion Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.89% over the forecast period (2024-2032)

Based on product type segmentation, tethered pump was predicted to show maximum market share in the year 2023

Based on patient type segmentation, type 1 was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Subcutaneous Insulin Infusion Market- Segmentation Analysis:

The Global Continuous Subcutaneous Insulin Infusion Market is segmented based on Product Type, Patient Type, End-use, and Region.

The market is divided into three categories based on product type: patch pumps and tethered pumps. The tethered pumps sector dominates the market. The air-to-air heat pump requires very little maintenance and is simple to install. It is chosen over ground source heat pump systems since there are no groundwork costs and it is more cost-effective.

The market is divided into two categories based on patient type: type 1 and type 2. The type 1 sector dominates the market and is likely to maintain its dominance during the forecast period. This is majorly due to its accessibility and portability, capturing a significant market share. These devices, easily worn under or outside clothing, offer convenience for insulin management.

Continuous Subcutaneous Insulin Infusion Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Continuous Subcutaneous Insulin Infusion Market- Competitive Landscape:

The global market is driven by the growing adoption of advanced insulin management solutions, emphasizing user-friendly technology and improved glycemic control. Market strategies include partnerships to enhance device integration with glucose monitoring systems, enabling real-time data and predictive analytics for proactive diabetes management. Additionally, companies are focusing on developing compact, discreet insulin pumps and customizable dosing options to cater to specific patient needs, particularly in managing type 1 diabetes across diverse demographics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic Inc.
  • CeQur
  • Tandem Diabetes Care
  • F Hoffmann-La Roche
  • Ypsomed
  • Insulet Corporation
  • Sooil Development
  • Valeritas Inc.
  • Cellenovo
  • B. Braun Melsungen AG
  • Bigfoot Biomedical, Inc.
  • Becton, Dickinson and Company
  • Fresenius SE & Co. KGaA
  • MicroPort Scientific Corporation
  • MannKind Corporation
  • Nipro Corporation
  • Shinmyung Mediyes CO., LTD.
  • Sanofi S.A.
  • Smiths Group PLC
  • Others

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Patch Pumps
  • Bolus
  • Basal
  • Basal & Bolus
  • Tethered Pumps
  • Battery
  • Insulin Set Insertion Devices
  • Insulin Reservoir & Cartridges

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Type 1
  • Type 2

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Homecare
  • Hospitals

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Subcutaneous Insulin Infusion Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Subcutaneous Insulin Infusion Market Snippet by Product Type
    • 2.1.2. Continuous Subcutaneous Insulin Infusion Market Snippet by Patient Type
    • 2.1.3. Continuous Subcutaneous Insulin Infusion Market Snippet by End-use
    • 2.1.4. Continuous Subcutaneous Insulin Infusion Market Snippet by Country
    • 2.1.5. Continuous Subcutaneous Insulin Infusion Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Subcutaneous Insulin Infusion Key Market Trends

  • 3.1. Continuous Subcutaneous Insulin Infusion Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Subcutaneous Insulin Infusion Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Subcutaneous Insulin Infusion Market Opportunities
  • 3.4. Continuous Subcutaneous Insulin Infusion Market Future Trends

4. Continuous Subcutaneous Insulin Infusion Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Subcutaneous Insulin Infusion Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Continuous Subcutaneous Insulin Infusion Market Landscape

  • 6.1. Continuous Subcutaneous Insulin Infusion Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Subcutaneous Insulin Infusion Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Patch Pumps
      • 7.1.2.1. Basal & Bolus
      • 7.1.2.2. Basal
      • 7.1.2.3. Bolus
    • 7.1.3. Tethered Pumps
      • 7.1.3.1. Battery
      • 7.1.3.2. Insulin Set Insertion Devices
      • 7.1.3.3. Insulin Reservoir & Cartridges

8. Continuous Subcutaneous Insulin Infusion Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Type 1
    • 8.1.3. Type 2

9. Continuous Subcutaneous Insulin Infusion Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
    • 9.1.3. Homecare
    • 9.1.4. Hospitals

10. Continuous Subcutaneous Insulin Infusion Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Continuous Subcutaneous Insulin Infusion Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Medtronic Inc.
    • 11.2.2. CeQur
    • 11.2.3. Tandem Diabetes Care
    • 11.2.4. F Hoffmann-La Roche
    • 11.2.5. Ypsomed
    • 11.2.6. Insulet Corporation
    • 11.2.7. Sooil Development
    • 11.2.8. Valeritas Inc.
    • 11.2.9. Cellenovo
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Bigfoot Biomedical, Inc.
    • 11.2.12. Becton, Dickinson and Company
    • 11.2.13. Fresenius SE & Co. KGaA
    • 11.2.14. MicroPort Scientific Corporation
    • 11.2.15. MannKind Corporation
    • 11.2.16. Nipro Corporation
    • 11.2.17. Shinmyung Mediyes CO., LTD.
    • 11.2.18. Sanofi S.A.
    • 11.2.19. Smiths Group PLC
    • 11.2.20. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us